GAXOS.AI Reports Doubled Net Loss and 43% Share Dilution Despite Significant Revenue Growth
GXAI sits 21% above its 52-week low of $1.02.
Summary
GAXOS.AI reported a significant increase in Q1 2026 revenue but also a doubling of net loss due to soaring operating expenses. The company raised $5.3 million through a highly dilutive ATM offering, increasing shares outstanding by 43.5% to fund operations and a $2.9 million acquisition.
Key Events · Earnings and Guidance · GXAI
-
Revenue Surges, Losses Double
Q1 2026 revenue increased to $1.81 million from $23,732 in Q1 2025, driven by RNK Health administrative services and Gaxos Labs subscriptions. However, operating expenses rose 207.8%, causing net loss to double to $2.47 million.
-
Significant Dilutive Financing
The company issued 3,096,481 common shares through an At-The-Market (ATM) offering, generating $5.3 million in net proceeds. This represents a 43.5% increase in shares outstanding in one quarter.
-
Cash Runway Secured
Despite a quarterly cash burn of $2.49 million from operations, the ATM proceeds, along with existing working capital and short-term investments, are expected to provide sufficient liquidity for the next 12 months.
-
Strategic Acquisition Completed
GAXOS.AI completed a $2.9 million acquisition of a 19.99% stake in America First Defense.AI LLC on March 4, 2026.
Analysis · GXAI · Technology
GAXOS.AI's Q1 2026 results show a substantial increase in revenue, primarily from administrative and subscription services. However, this growth came at a high cost, with operating expenses more than doubling, leading to a significant increase in net loss. The company funded its operations and a strategic acquisition through a highly dilutive At-The-Market (ATM) offering, which increased outstanding shares by over 43% in a single quarter. While the ATM provides a 12-month cash runway, the aggressive cash burn and dilution raise concerns about the sustainability of its growth strategy.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GXAI was trading at $1.23 on NASDAQ in the Technology sector, with a market capitalization of approximately $12.5M. The 52-week trading range was $1.02 to $2.96. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.